Found: 2
Select item for more details and to access through your institution.
Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 2, p. 63, doi. 10.1002/acr2.11517
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study.
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 123, doi. 10.2147/CPAA.S305308
- By:
- Publication type:
- Article